Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1306 to 1320 of 1877 results for do not dos

  1. Guidance on the use of electroconvulsive therapy (TA59)

    Evidence-based recommendations on electroconvulsive therapy (ECT) for treating catatonia, prolonged or severe manic episodes or schizophrenia in adults.

    Technology appraisal guidance
    Last updated
    1 October 2009
    View recommendations

    Sections for TA59

  2. Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease (TA607)

    Evidence-based recommendations on rivaroxaban (Xarelto) for preventing atherothrombotic events in adults with coronary or peripheral artery disease.

    Technology appraisal guidance
    Published
    17 October 2019
    View recommendations

    Sections for TA607

  3. CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack (HTG724)

    Evidence-based recommendations on CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack.

    HealthTech guidance
    Published
    31 July 2024
    View recommendations

    Sections for HTG724

  4. myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)

    NICE has developed a medtech innovation briefing (MIB) on myAIRVO2 for the treatment of chronic obstructive pulmonary disease .

    Medtech innovation briefing
    Published
    1 October 2018

  5. What components of alcohol education delivery contribute to its effectiveness for children and young people aged 11 to 18 in full-time education, and those with special educational needs and disabilities (SEND) up to the age of 25?

    committee agreed that the spiral curriculum concept is a logical approach to do this. No evidence was identified for alcohol education...

    Research recommendation
    Published
    25 October 2019

  6. How effective and cost effective are education-based alcohol interventions targeted at children and young people aged 11 to 25 with SEND who are thought to be vulnerable to alcohol misuse?

    committee agreed that the spiral curriculum concept is a logical approach to do this. No evidence was identified for alcohol education...

    Research recommendation
    Published
    25 October 2019

  7. How effective are education-based alcohol prevention interventions (universal or targeted) for children and young people aged 11 to 25 with SEND in full-time education?

    committee agreed that the spiral curriculum concept is a logical approach to do this. No evidence was identified for alcohol education...

    Research recommendation
    Published
    25 October 2019

  8. What is the cost effectiveness and safety of non-surgical ablation and stereotactic body radiotherapy compared to resection for people with metastatic colorectal cancer in the lung amenable to local treatment?

    teams that specialise in primary lung disease may not be appropriate as they do not specialise in the management of lung metastases from...

    Research recommendation
    Published
    10 February 2020

  9. What is the most clinically and cost-effective treatment for diverticular disease?

    causes and further investigations in people with persistent symptoms or who do not respond to treatment. How the recommendations might...

    Research recommendation
    Published
    10 February 2020

  10. How effective and cost effective are universal, education-based alcohol interventions for children and young people aged 11 to 25 with SEND?

    committee agreed that the spiral curriculum concept is a logical approach to do this. No evidence was identified for alcohol education...

    Research recommendation
    Published
    25 October 2019

  11. Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer (TA632)

    Evidence-based recommendations on trastuzumab emtansine (Kadcyla) for human epidermal growth factor receptor 2 (HER2)-positive early breast cancer in adults who have residual invasive disease in the breast or lymph nodes after neoadjuvant taxane-based and HER2-targeted therapy.

    Technology appraisal guidance
    Published
    10 June 2020
    View recommendations

    Sections for TA632

  12. Granulox for managing chronic non-healing wounds (MIB296)

    NICE has developed a medtech innovation briefing (MIB) on Granulox for managing chronic non-healing wounds .

    Medtech innovation briefing
    Published
    10 May 2022

  13. What interventions are effective and cost effective in supporting return to work after recurrent short-term sickness absence in the UK?

    need similar support when returning to work. The recommendations therefore do not distinguish between supporting people returning from...

    Research recommendation
    Published
    10 February 2020

  14. Early pregnancy assessment units: A national evaluation of early pregnancy assessment unit service provision should be carried out to identify factors affecting outcomes. Factors should include whether care is provided in a dedicated unit, staffing configuration and opening hours of dedicated services. Outcomes should include both process (service) outcomes and pregnancy-related outcomes. Data collected should be used to analyse the cost effectiveness of early pregnancy assessment units compared with other models of care.

    pregnancy services carrying out more formal follow‑up of women than they might do currently, for the duration of the audit. The...

    Research recommendation
    Published
    17 December 2021

  15. Recommendation 1 Research studies and trials. Who should take action? Research councils, commissioners and funders.

    questionnaire to investigate dietary intake. If validated tools for secondary measures do not exist, a tool to measure the outcome (for...

    Research recommendation
    Published
    9 June 2015